Samuel Constant

Dr. Samuel Constant, Ph.D, Chief Executive Officer, Co-Founder of Epithelix, is a synthetic organic chemist, with 20 years of research experiences in several countries (Switzerland, France, UK and Japan). He also has expertise in in vitro test method development. He is in charge of the company's global Management, Business Development and Partnership. Samuel is also CEO of OncoTheis.